Stockreport

Amgen dismisses bone density concerns related to its new weight-loss drug [Yahoo! Finance Canada]

Amgen Inc.  (AMGN) 
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
PDF "The Phase 1 study results do not suggest any bone safety concern or change our conviction in the promise of MariTide," Amgen said, adding that it looks forward to data [Read more]